Giuseppe Tarantino, PhD
@giuseppetara.bsky.social
Instructor in Medicine at @DanaFarber @harvardmed @broadinstitute | PhD in Oncology at University of Bologna | visiting scientist @wharton
I'm running the Chicago Marathon with Crohn’s & Colitis Foundation Team Challenge to support those affected by Crohn's & Colitis. Join me in making a difference—every donation brings us closer to better treatments and a cure! 🏃♂️💙 Donate here:
teamchallenge.crohnscolitisfoundation.org/index.cfm?fu...
teamchallenge.crohnscolitisfoundation.org/index.cfm?fu...
I'm fundraising for IBD cures!
I am participating in the 2025 Bank of America Chicago Marathon and raising funds for the Crohn’s & Colitis Foundation. With every mile, I hope to further their mission of finding cures for Crohn's di...
teamchallenge.crohnscolitisfoundation.org
January 13, 2025 at 7:09 PM
I'm running the Chicago Marathon with Crohn’s & Colitis Foundation Team Challenge to support those affected by Crohn's & Colitis. Join me in making a difference—every donation brings us closer to better treatments and a cure! 🏃♂️💙 Donate here:
teamchallenge.crohnscolitisfoundation.org/index.cfm?fu...
teamchallenge.crohnscolitisfoundation.org/index.cfm?fu...
In this review we summarizes recent advancements in melanoma immunotherapy with an emphasis on key tumor-intrinsic and -extrinsic mechanisms driving resistance.
#melanoma #immunotherapy #Resistance
link.springer.com/article/10.1...
#melanoma #immunotherapy #Resistance
link.springer.com/article/10.1...
Overcoming Resistance Mechanisms to Melanoma Immunotherapy - American Journal of Clinical Dermatology
The advent of immune checkpoint inhibition has revolutionized treatment of advanced melanoma. While most patients derive survival benefit from established immunotherapies, notably monoclonal antibodie...
link.springer.com
December 17, 2024 at 12:04 PM
In this review we summarizes recent advancements in melanoma immunotherapy with an emphasis on key tumor-intrinsic and -extrinsic mechanisms driving resistance.
#melanoma #immunotherapy #Resistance
link.springer.com/article/10.1...
#melanoma #immunotherapy #Resistance
link.springer.com/article/10.1...
1/10🚨 New Findings Alert! 🚨
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
November 29, 2024 at 9:43 PM
1/10🚨 New Findings Alert! 🚨
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇
Discover how genomic heterogeneity and ploidy help predict intrinsic resistance to anti-PD-1 immune checkpoint blockade (ICB) in metastatic melanoma. 🧬https://www.science.org/doi/10.1126/sciadv.adp4670
📝 Key takeaways from our latest study: 🧵👇